Suppr超能文献

经导管二尖瓣介入治疗的未来:修复与置换的竞争还是互补作用?

The future of transcatheter mitral valve interventions: competitive or complementary role of repair vs. replacement?

机构信息

University Hospital of Zurich, Rämistrasse 100, 8089-CH, Zurich, Switzerland

San Raffaele University Hospital, Milan, Italy.

出版信息

Eur Heart J. 2015 Jul 7;36(26):1651-9. doi: 10.1093/eurheartj/ehv123. Epub 2015 Apr 12.

Abstract

Transcatheter mitral interventions has been developed to address an unmet clinical need and may be an alternative therapeutic option to surgery with the intent to provide symptomatic and prognostic benefit. Beyond MitraClip therapy, alternative repair technologies are being developed to expand the transcatheter intervention armamentarium. Recently, the feasibility of transcatheter mitral valve implantation in native non-calcified valves has been reported in very high-risk patients. Acknowledging the lack of scientific evidence to date, it is difficult to predict what the ultimate future role of transcatheter mitral valve interventions will be. The purpose of the present report is to review the current state-of-the-art of mitral valve intervention, and to identify the potential future scenarios, which might benefit most from the transcatheter repair and replacement devices under development.

摘要

经导管二尖瓣介入治疗旨在满足未满足的临床需求,可能是手术治疗的替代治疗选择,旨在提供症状和预后获益。除了 MitraClip 治疗之外,还在开发替代修复技术来扩大经导管介入治疗的武器库。最近,在极高风险患者中报告了经导管二尖瓣置换术在原生非钙化瓣膜中的可行性。鉴于目前缺乏科学证据,很难预测经导管二尖瓣介入治疗的最终未来角色。本报告的目的是回顾二尖瓣介入治疗的最新现状,并确定潜在的未来场景,这些场景可能最受益于正在开发的经导管修复和置换装置。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验